KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Aurora Cannabis (ACB) Revenue (2017 - 2025)

Aurora Cannabis has reported Revenue over the past 9 years, most recently at $67.5 million for Q4 2025.

  • Quarterly Revenue rose 6.98% to $67.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $267.0 million through Dec 2025, up 14.3% year-over-year, with the annual reading at $239.2 million for FY2025, 19.56% up from the prior year.
  • Revenue was $67.5 million for Q4 2025 at Aurora Cannabis, up from $65.7 million in the prior quarter.
  • Over five years, Revenue peaked at $70.7 million in Q2 2025 and troughed at $37.3 million in Q3 2022.
  • The 5-year median for Revenue is $59.8 million (2022), against an average of $56.8 million.
  • The largest YoY upside for Revenue was 8845.71% in 2021 against a maximum downside of 64.52% in 2021.
  • A 5-year view of Revenue shows it stood at $54.8 million in 2021, then fell by 17.91% to $45.0 million in 2022, then increased by 5.07% to $47.3 million in 2023, then surged by 33.52% to $63.1 million in 2024, then increased by 6.98% to $67.5 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Revenue are $67.5 million (Q4 2025), $65.7 million (Q3 2025), and $70.7 million (Q2 2025).